v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Class A and Class B Common Stock
Class A and Class B Common Stock
Shares, beginning of period (in shares) at Jan. 31, 2022         270,451,615
Balance, beginning of period at Jan. 31, 2022 $ 1,650,788 $ 2,271,980 $ 454 $ (621,673) $ 27
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)         2,018,597
Issuance of common stock upon exercise of stock options 5,090 5,090      
Vesting of restricted stock units (in shares)         26,412
Vesting of early exercised stock options 18 18      
Stock-based compensation 32,417 32,417      
Other comprehensive income (1,237)   (1,237)    
Net loss (89,834)     (89,834)  
Shares, end of period (in shares) at Apr. 30, 2022         272,496,624
Balance, end of period at Apr. 30, 2022 1,597,242 2,309,505 (783) (711,507) $ 27
Shares, beginning of period (in shares) at Jan. 31, 2023         286,763,857
Balance, beginning of period at Jan. 31, 2023 1,656,705 2,663,394 (6,367) (1,000,351) $ 29
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)         3,701,792
Issuance of common stock upon exercise of stock options 9,762 9,762      
Vesting of restricted stock units (in shares)         759,416
Vesting of early exercised stock options 49 49      
Stock-based compensation 56,773 56,773      
Other comprehensive income 754   754    
Net loss (106,869)     (106,869)  
Shares, end of period (in shares) at Apr. 30, 2023         291,225,065
Balance, end of period at Apr. 30, 2023 $ 1,617,174 $ 2,729,978 $ (5,613) $ (1,107,220) $ 29